Brain MRI atrophy quantification in MS: From methods to clinical application.
Patients with the main clinical phenotypes of multiple sclerosis (MS) manifest varying degrees of brain atrophy beyond that of normal aging. Assessment of atrophy helps to distinguish clinically and cognitively deteriorating patients and predicts those who will have a less-favorable clinical outcome...
Prif Awduron: | Rocca, M, Battaglini, M, Benedict, R, De Stefano, N, Geurts, J, Henry, R, Horsfield, M, Jenkinson, M, Pagani, E, Filippi, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
American Academy of Neurology
2016
|
Eitemau Tebyg
-
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
gan: Houshang Amiri, et al.
Cyhoeddwyd: (2018-01-01) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
gan: Vrenken, H, et al.
Cyhoeddwyd: (2013) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
gan: Vrenken, H, et al.
Cyhoeddwyd: (2013) -
Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy
gan: Theodoros Ladopoulos, et al.
Cyhoeddwyd: (2022-01-01) -
Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
gan: Storelli, L, et al.
Cyhoeddwyd: (2018)